Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2013, Vol 67, Issue 0
Abstract
Chronic lymphocytic leukemia (CLL) patients are at high risk for infections. The pathogenesis of infection in patients with this leukemia is complex and multifactorial. Patients with CLL have a number of immune system defects, including disordered B-cell function with decreased production of normal B-cells and abnormal production of immunoglobulins, suppressed Tcell function and neutropenia. Other immune abnormalities present in CLL patients include neutrophil dysfunction, and complement deficiencies. In addition, further perturbations in immune function are related to the antileukemic therapies. Immune disturbance might be common prior to CLL diagnosis and infectious agents could trigger CLL development. Current chemotherapy-based regimens are not curative and often worsen this immune suppression. The introduction of new effective therapeutic agents such as the purine analogues and monoclonal antibodies has influenced the spectrum of infections diagnosed in CLL patients. Some conditions increase the risk for the development of infections including advanced age, decreased levels of immunoglobulins, advanced Binet stage, neutropenia and treatment with more than one line of chemotherapy. Until now it is debatable whether and when antibacterial prophylaxis could be useful in CLL patients. The prevention of infection includes antimicrobial prophylaxis, as well as immunoglobulin replacement and vaccination. Antibacterial prophylaxis should be given to CLL patients with previous severe and/or relapsing bacterial infections. This article reviews the immune defects in CLL and discusses strategies aimed at prophylaxis and treatment of infections in patients with CLL.
Authors and Affiliations
Piotr Stelmach, Tadeusz Robak
Keywords
Related Articles
- EP ID EP66959
- DOI -
- Views 156
- Downloads 0
Mimetyki BH3 jako terapia wspomagająca konwencjonalne leki przeciwnowotworowe
Poznanie mechanizmów regulujących proces apoptozy umożliwiło rozwój nowych terapii przeciwnowotworowych. Zaburzenia ekspresji lub aktywności regulatorów mitochondrialnego szlaku apoptozy leżą u podstaw rozwoju nowotworów...
Związek markerów zapalenia z zespołem metabolicznym i arytmią komorową u pacjentów z chorobą wieńcową
Mechanisms of osteoporosis development in patients with rheumatoid arthritis
Rheumatoid arthritis (RA) is progressive, chronic, autoimmune, systemic connective tissue disease. It affects 0,5-1% population. RA manifests as inflammation of symmetrical mainly small and medium joints with synovial hy...
Antagoniści receptorów endotelinowych (ERA) – krótka charakterystyka nowej grupy leków
Endoteliny – śródbłonkowe peptydy, których właściwości są badane od ponad 25 lat, odgrywająszczególną rolę w patofizjologii wielu chorób, głównie obejmujących układ sercowo-naczyniowy.Najlepiej dotychczas zbadana endotel...
Selected aspects of Clostridium difficile infection
Clostridium difficile pathogen is a cause of the most frequent nosocomial infection, which is antibiotic-associated diarrhea. Antibiotic treatment causes disruption of the microbiome balance, which makes the gut a friend...